IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 Study September 19, 2019November 6, 2019 by Alejandro
IGC Reports Financial Results for the Quarter Ended June 30, 2019 August 8, 2019November 6, 2019 by charlie
IGC Reports Financial Results for the Fiscal Year Ended March 31, 2019 June 14, 2019September 10, 2019 by charlie
IGC Announces Successful Appeal of Delisting Proceedings and Imminent Relisting on NYSE American February 22, 2019September 10, 2019 by charlie
IGC Announces Extension of Expiration Date and Reduction of Exercise Price of its Publicly Traded Warrants February 20, 2019September 10, 2019 by charlie
IGC Announces Financial Results for Quarter Ended December 31, 2018 February 12, 2019September 10, 2019 by charlie
NYSE American to Suspend Trading in India Globalization Capital and Commence Delisting Proceedings October 29, 2018September 10, 2019 by charlie
IGC Announces Financial Results for Quarter Ended September 30, 2018 October 16, 2018September 10, 2019 by charlie
IGC Files Provisional Patent to Protect IP for CBD-Infused Energy Drink October 9, 2018September 10, 2019 by charlie
